SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-150904
Filing Date
2011-05-26
Accepted
2011-05-26 06:13:06
Documents
8
Period of Report
2011-05-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 16038
2 ORDER OF THE U.S. DISTRICT COURT DATED MAY 23, 2011 dex991.htm EX-99.1 46773
3 GRAPHIC g194133g14l12.jpg GRAPHIC 201645
4 GRAPHIC g194133g20y40.jpg GRAPHIC 88167
5 GRAPHIC g194133g23t17.jpg GRAPHIC 132134
6 GRAPHIC g194133g29i57.jpg GRAPHIC 188836
7 GRAPHIC g194133g35s27.jpg GRAPHIC 200032
8 GRAPHIC g194133g77h02.jpg GRAPHIC 152014
  Complete submission text file 0001193125-11-150904.txt   1391380
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 11872533
SIC: 2834 Pharmaceutical Preparations